![Michal Preminger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michal Preminger
Direktor/Vorstandsmitglied bei
Massachusetts Biotechnology Council
Profil
Michal Preminger is the founder of Anima Cell Metrology, Inc. Currently, she is the Director at Massachusetts Biotechnology Council.
In the past, she has worked as Non-Executive Chairman at Bioarray Genetics, Director at Compugen Ltd., Director-Marketing & Business Development at Lucent Technologies, Senior Director-Business Development at Office of Technology Development, Director at Firefly Neuroscience Ltd., and Vice President-Protein Therapeutics at Compugen Ltd. Dr. Preminger holds an MBA degree from INSEAD, an undergraduate degree from The Hebrew University of Jerusalem, and a doctorate degree from Weizmann Institute of Science.
Aktive Positionen von Michal Preminger
| Unternehmen | Position | Beginn |
|---|---|---|
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direktor/Vorstandsmitglied | 20.05.2021 |
Ehemalige bekannte Positionen von Michal Preminger
| Unternehmen | Position | Ende |
|---|---|---|
| COMPUGEN LTD. | Direktor/Vorstandsmitglied | 06.08.2018 |
Firefly Neuroscience Ltd.
 Firefly Neuroscience Ltd. Miscellaneous Commercial ServicesCommercial Services Develops mapping and quantified neural communication for brain diagnostics | Direktor/Vorstandsmitglied | 01.03.2016 |
| COMPUGEN LTD. | Corporate Officer/Principal | 01.08.2004 |
Bioarray Genetics, Inc.
 Bioarray Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a patent-pending chemotherapy response assay to help guide physicians in the selection of the most effective treatments | Vorsitzender | - |
Office of Technology Development
 Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Private-Equity-Analyst | 06.10.2010 |
Ausbildung von Michal Preminger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lucent Technologies
 Lucent Technologies Telecommunications EquipmentElectronic Technology Designs, develops and manufactures telecommunications systems, software and products | Electronic Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Anima Cell Metrology, Inc.
 Anima Cell Metrology, Inc. Packaged SoftwareTechnology Services Develops biotech platform | Technology Services |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development invests in companies located in the United States. The firm focuses on health and technology sectors. It participates in early-stage transactions. | Finance |
Bioarray Genetics, Inc.
Bioarray Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops a patent-pending chemotherapy response assay to help guide physicians in the selection of the most effective treatments | Commercial Services |
Firefly Neuroscience Ltd.
Firefly Neuroscience Ltd. Miscellaneous Commercial ServicesCommercial Services Develops mapping and quantified neural communication for brain diagnostics | Commercial Services |
